IL6 and Alzheimer disease: To further investigate the role of IL-6 signaling in bone marrow B-cell production in AD mice, the 3-month-old 5×FAD mice received an intraperitoneal injection of an FDA-approved monoclonal antibody (tocilizumab) that blocks the IL-6 receptor (Fig. 6a).